United States ADHD Drugs Market Report 2016

United States ADHD Drugs Market Report 2016

1 ADHD Drugs Overview

1.1 Product Overview and Scope of ADHD Drugs

1.2 Classification of ADHD Drugs

1.2.1 Stimulants (Amphetamines, Methylphenidate)

1.2.2 Non-Stimulants

1.2.3 Antidepressants

1.2.4 Blood Pressure Medicines

1.3 Application of ADHD Drugs

1.3.1 Adults

1.3.2 Children

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of ADHD Drugs (2011-2021)

1.4.1 United States ADHD Drugs Sales and Growth Rate (2011-2021)

1.4.2 United States ADHD Drugs Revenue and Growth Rate (2011-2021)

2 United States ADHD Drugs Competition by Manufacturers

2.1 United States ADHD Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States ADHD Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States ADHD Drugs Average Price by Manufactures (2015 and 2016)

2.4 ADHD Drugs Market Competitive Situation and Trends

2.4.1 ADHD Drugs Market Concentration Rate

2.4.2 ADHD Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States ADHD Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States ADHD Drugs Sales and Market Share by Type (2011-2016)

3.2 United States ADHD Drugs Revenue and Market Share by Type (2011-2016)

3.3 United States ADHD Drugs Price by Type (2011-2016)

3.4 United States ADHD Drugs Sales Growth Rate by Type (2011-2016)

4 United States ADHD Drugs Sales (Volume) by Application (2011-2016)

4.1 United States ADHD Drugs Sales and Market Share by Application (2011-2016)

4.2 United States ADHD Drugs Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States ADHD Drugs Manufacturers Profiles/Analysis

5.1 Eli Lilly

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 ADHD Drugs Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Eli Lilly ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Janssen Pharmaceuticals, Inc.

5.2.2 ADHD Drugs Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Shire

5.3.2 ADHD Drugs Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Shire ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Perdue Pharma

5.4.2 ADHD Drugs Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Perdue Pharma ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Glaxosmith Kline

5.5.2 ADHD Drugs Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Glaxosmith Kline ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Decartis

5.6.2 ADHD Drugs Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Decartis ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Celltech Group

5.7.2 ADHD Drugs Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Celltech Group ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Johnson & Johnson

5.8.2 ADHD Drugs Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Johnson & Johnson ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

6 ADHD Drugs Manufacturing Cost Analysis

6.1 ADHD Drugs Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of ADHD Drugs

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 ADHD Drugs Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of ADHD Drugs Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States ADHD Drugs Market Forecast (2016-2021)

10.1 United States ADHD Drugs Sales, Revenue Forecast (2016-2021)

10.2 United States ADHD Drugs Sales Forecast by Type (2016-2021)

10.3 United States ADHD Drugs Sales Forecast by Application (2016-2021)

10.4 ADHD Drugs Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of ADHD Drugs

Table Classification of ADHD Drugs

Figure United States Sales Market Share of ADHD Drugs by Type in 2015

Figure Stimulants (Amphetamines, Methylphenidate) Picture

Figure Non-Stimulants Picture

Figure Antidepressants Picture

Figure Blood Pressure Medicines Picture

Table Application of ADHD Drugs

Figure United States Sales Market Share of ADHD Drugs by Application in 2015

Figure Adults Examples

Figure Children Examples

Figure United States ADHD Drugs Sales and Growth Rate (2011-2021)

Figure United States ADHD Drugs Revenue and Growth Rate (2011-2021)

Table United States ADHD Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States ADHD Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 ADHD Drugs Sales Share by Manufacturers

Figure 2016 ADHD Drugs Sales Share by Manufacturers

Table United States ADHD Drugs Revenue by Manufacturers (2015 and 2016)

Table United States ADHD Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States ADHD Drugs Revenue Share by Manufacturers

Table 2016 United States ADHD Drugs Revenue Share by Manufacturers

Table United States Market ADHD Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market ADHD Drugs Average Price of Key Manufacturers in 2015

Figure ADHD Drugs Market Share of Top 3 Manufacturers

Figure ADHD Drugs Market Share of Top 5 Manufacturers

Table United States ADHD Drugs Sales by Type (2011-2016)

Table United States ADHD Drugs Sales Share by Type (2011-2016)

Figure United States ADHD Drugs Sales Market Share by Type in 2015

Table United States ADHD Drugs Revenue and Market Share by Type (2011-2016)

Table United States ADHD Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of ADHD Drugs by Type (2011-2016)

Table United States ADHD Drugs Price by Type (2011-2016)

Figure United States ADHD Drugs Sales Growth Rate by Type (2011-2016)

Table United States ADHD Drugs Sales by Application (2011-2016)

Table United States ADHD Drugs Sales Market Share by Application (2011-2016)

Figure United States ADHD Drugs Sales Market Share by Application in 2015

Table United States ADHD Drugs Sales Growth Rate by Application (2011-2016)

Figure United States ADHD Drugs Sales Growth Rate by Application (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Eli Lilly ADHD Drugs Sales Market Share (2011-2016)

Table Janssen Pharmaceuticals, Inc. Basic Information List

Table Janssen Pharmaceuticals, Inc. ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Janssen Pharmaceuticals, Inc. ADHD Drugs Sales Market Share (2011-2016)

Table Shire Basic Information List

Table Shire ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Shire ADHD Drugs Sales Market Share (2011-2016)

Table Perdue Pharma Basic Information List

Table Perdue Pharma ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Perdue Pharma ADHD Drugs Sales Market Share (2011-2016)

Table Glaxosmith Kline Basic Information List

Table Glaxosmith Kline ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Glaxosmith Kline ADHD Drugs Sales Market Share (2011-2016)

Table Decartis Basic Information List

Table Decartis ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Decartis ADHD Drugs Sales Market Share (2011-2016)

Table Celltech Group Basic Information List

Table Celltech Group ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Celltech Group ADHD Drugs Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson ADHD Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson ADHD Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of ADHD Drugs

Figure Manufacturing Process Analysis of ADHD Drugs

Figure ADHD Drugs Industrial Chain Analysis

Table Raw Materials Sources of ADHD Drugs Major Manufacturers in 2015

Table Major Buyers of ADHD Drugs

Table Distributors/Traders List

Figure United States ADHD Drugs Production and Growth Rate Forecast (2016-2021)

Figure United States ADHD Drugs Revenue and Growth Rate Forecast (2016-2021)

Table United States ADHD Drugs Production Forecast by Type (2016-2021)

Table United States ADHD Drugs Consumption Forecast by Application (2016-2021)